glp 1 stomach pain and diarrhea Bloating from GLP-1 Injections Struggling with GLP-1 therapy side
Description
When a recently-eaten meal reaches cells in the intestine, they release a glucagon-like peptide 1, or GLP-1
This interaction sends signals to the brain suggesting fullness, subsequently decreasing the individuals appetite, leading to a reduction in food intake and aiding in weight loss
Participants also self-reported their daily servings of MyPlate food groups
Patients must also consider the financial implications, as off-label use may not be NHS-funded, potentially incurring substantial private costs
No appointment needed
Maki PM, Jaff NG
